Clinical Features of Tachycardia-induced Cardiomyopathy in Patients with Atrial Fibrillation

被引:2
|
作者
Uotani, Yukimi [1 ]
Sasaki, Nobuo [2 ]
Nakashima, Mika [1 ]
Akiyama, Rie [1 ]
Oguri, Naoto [1 ]
Miyamoto, Shogo [1 ]
Miyauchi, Shunsuke [1 ]
Okamura, Sho [1 ]
Okubo, Yousaku [1 ]
Tokuyama, Takehito [1 ]
Ohno, Haruya [3 ]
Nakano, Yukiko [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan
[2] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Higashihiroshima, Japan
关键词
atrial fibrillation; cardiomyopathy; diabetes; tachycardia; HEART-FAILURE; VENTRICULAR DYSFUNCTION; RISK-FACTORS; RECOVERY; ABLATION; RHYTHM; ASSOCIATION; PREDICTORS; MECHANISMS;
D O I
10.2169/internalmedicine.2466-23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Atrial fibrillation (AF) is the most common cause of tachycardia-induced cardiomyopathy (TIC). However, which patients with AF are prone to developing TIC remains unclear. In this study, we investigated the clinical features of AF patients with TIC. Methods This single-center study included 722 patients with AF (average age, 63.1 +/- 10.2 years old; 191 women) who underwent radiofrequency catheter ablation. We defined TIC as an initial left ventricular ejection fraction (LVEF) of <40% and a >20% recovery of the LVEF after successful AF ablation and compared the clinical characteristics between the TIC and control groups. Results The proportions of type 2 diabetes (30.5% vs. 14.7%), renal dysfunction (34.2% vs. 23.8%), hypertension (67.1% vs. 54.8%), and persistent AF (62.2% vs. 32.2%) were significantly higher in the TIC group (n=82) than in the control group (n=640). The atrioventricular nodal effective refractory period (AVNERP) (303 +/- 72 ms vs. 332 +/- 86 ms; p=0.017) was significantly shorter in the TIC group than in the control group. A multivariable analysis found that persistent AF [odds ratio (OR), 3.19; 95% confidence interval (CI), 1.945.24], renal dysfunction (OR, 1.87; 95% CI, 1.06-3.32), and type 2 diabetes (OR, 2.30; 95% CI, 1.31-4.05) were significantly associated with TIC. Conclusion Comorbid renal dysfunction and type 2 diabetes were clinical features of AF patients with TIC. Persistent AF, and short AVNERP may be involved in the development of TIC.
引用
收藏
页码:2509 / 2517
页数:9
相关论文
共 50 条
  • [41] Tachycardia-induced cardiomyopathy:: mechanisms of heart failure and clinical implications
    Calo, Leonardo
    De Ruvo, Ermenegildo
    Sette, Antonella
    Sciarra, Luigi
    Scioli, Roberto
    Sebastiani, Francesco
    Topai, Marco
    Iulianella, Renzo
    Navone, Giovanna
    Lioy, Ernesto
    Gaita, Fiorenzo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2007, 8 (03) : 138 - 143
  • [42] Heart failure and tachycardia-induced cardiomyopathy
    Ellis E.R.
    Josephson M.E.
    Current Heart Failure Reports, 2013, 10 (4) : 296 - 306
  • [43] What About Tachycardia-induced Cardiomyopathy?
    Ellis, Ethan R.
    Josephson, Mark E.
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2013, 2 (02) : 82 - 90
  • [44] Tachycardia-induced cardiomyopathy: A review of literature
    Khasnis, A
    Jongnarangsin, K
    Abela, G
    Veerareddy, S
    Reddy, V
    Thakur, R
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (07): : 710 - 721
  • [45] Electrophysiological remodeling in tachycardia-induced cardiomyopathy
    Pabel, S.
    Knierim, M.
    Stehle, T.
    Poeppl, A.
    Hasenfuss, G.
    Maier, L.
    Streckfuss-Boemeke, K.
    Sossalla, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2889 - 2889
  • [46] RADIOFREQUENCY CATHETER ABLATION OF FOCAL ATRIAL TACHYCARDIA AS A TREATMENT OF TACHYCARDIA-INDUCED DILATED CARDIOMYOPATHY IN A DOG
    Noszczyk-Nowak, Agnieszka
    Fuglewicz, Artur
    Nowak, Krzysztof
    Skrzypczak, Piotr
    Janiszewski, Adrian
    Paslawska, Urszula
    Nicpon, Jozef
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2011, 55 (02) : 267 - 271
  • [47] Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia
    Nerheim, P
    Birger-Botkin, S
    Piracha, L
    Olshansky, B
    CIRCULATION, 2004, 110 (03) : 247 - 252
  • [48] Long-term outcomes of patients with tachycardia-induced cardiomyopathy
    Serban, T.
    Weidlich, S.
    Pfister, O.
    Kuehne, M.
    Sticherling, C.
    Badertscher, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [49] PRESENCE OF ATRIAL-NATRIURETIC-FACTOR IN VENTRICULAR TISSUE IN TACHYCARDIA-INDUCED CARDIOMYOPATHY
    LLOYD, MA
    GROGAN, M
    SANDBERG, SM
    SMITH, HC
    GERSH, BJ
    EDWARDS, WD
    EDWARDS, BS
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (13): : 984 - 986
  • [50] Tachycardia-Induced Cardiomyopathy in an Infant with Atrial Flutter and Prolonged Recovery of Cardiac Function
    Sakai, Tomohide
    Tsuboi, Kaori
    Takarada, Shinya
    Okabe, Mako
    Nakaoka, Hideyuki
    Ibuki, Keijiro
    Ozawa, Sayaka W.
    Hata, Yukiko
    Ichimata, Shojiro
    Nishida, Naoki
    Hirono, Keiichi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)